3692:HKG
Hansoh Pharmaceutical Group Company Ltd
31,74 HK$
arrow_upward
+1,15%(+0,36) 1D
16 қаз., 16:08:14 GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 3692...
Open
31,72 HK$
High
32,44 HK$
Low
31,52 HK$
Mkt. cap
192,48 млрд
Avg. vol.
8,58 млн
Volume
10,50 млн
Dividend
1,53%
Quarterly dividend
0,12 HK$
Ex-dividend date
2026 ж. 22 қыр.
P/E ratio
24,51
52-wk high
44,22 HK$
52-wk low
28,06 HK$
EPS
1,30 HK$
No. of employees
10 мың
Open
31,72 HK$
High
32,44 HK$
Low
31,52 HK$
Mkt. cap
192,48 млрд
Avg. vol.
8,58 млн
Volume
10,50 млн
Dividend
1,53%
Quarterly dividend
0,12 HK$
Ex-dividend date
2026 ж. 22 қыр.
P/E ratio
24,51
52-wk high
44,22 HK$
52-wk low
28,06 HK$
EPS
1,30 HK$
No. of employees
10 мың
News stories
From web sources and news partners
ad-hoc-news.de
·
1 күн бұрын
Hansoh Pharma stock gets HKD 47.82 consensus target
Profile
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
About Hansoh Pharmaceutical Group Company Ltd